The results of this study indicate that in vivo administration of Bay, the NF-kB inhibitor is well tolerated and highly effective in inhibiting the growth of fibroids, decreasing tumor weight by 50% after two months of treatment. This evidence concerns the gene NFKB1 and neoplasm.